Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
0.9825
+0.0225 (2.34%)
At close: Dec 16, 2025, 4:00 PM EST
0.9406
-0.0419 (-4.26%)
After-hours: Dec 16, 2025, 7:56 PM EST
Revelation Biosciences Employees
Revelation Biosciences had 9 employees as of December 31, 2024. The number of employees decreased by 1 or -10.00% compared to the previous year.
Employees
9
Change (1Y)
-1
Growth (1Y)
-10.00%
Revenue / Employee
n/a
Profits / Employee
-$1,564,432
Market Cap
5.82M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9 | -1 | -10.00% |
| Dec 31, 2023 | 10 | 4 | 66.67% |
| Dec 31, 2022 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
REVB News
- 15 days ago - Revelation Biosciences Has Reached A Quorum For Its December 3, 2025 Special Meeting - Accesswire
- 26 days ago - Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year - Accesswire
- 5 weeks ago - Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025 - Accesswire
- 6 weeks ago - Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date - Accesswire
- 2 months ago - Revelation Biosciences Inc. Announces Adjournment of October 15, 2025 Special Meeting of Stockholders to October 29, 2025 - Accesswire
- 3 months ago - Revelation Biosciences Inc. Announces Exercise of Warrants for $9.6 Million in Gross Proceeds - Accesswire
- 3 months ago - Revelation Biosciences Announces Special Webcast to Review Positive Top-line Clinical Data - Accesswire
- 3 months ago - Reminder - Webcast/Conference Call to Discuss Fantastic PRIME Phase 1b Top-line Data - Accesswire